BRAF and malignant colon neoplasm: Oncogenic mutations activating the WNT signaling pathway were a universal feature of serrated tumors in the model Smad4KO BRAFV600E/+, indicating that the combination of BRAF, SMAD4, and WNT mutations is critical for the progression of serrated colon cancers [9,18,19,21].